Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Unlocking the pathways of endocrine resistance


07 Oct 2016


New developments in the management of ER-positive metastatic breast cancer


Giuseppe Curigliano


G. Curigliano

Author affiliations

  • Drug Development, Istituto Europeo di Oncologia, 20141 - Milano/IT


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings